Log In
Print
BCIQ
Print
Print this Print this
 

ATG-Fresenius S

  Manage Alerts
Collapse Summary General Information
Company Fresenius SE & Co. KGaA
DescriptionPolyclonal antibody preparation for T lymphocyte suppression
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today